INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...

Abstract Background The effectiveness of erythropoiesis-stimulating agents, which are the main stay of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate body iron stores. The iron stores are determined by the levels of serum ferritin concentration and transferrin sat...

Full description

Bibliographic Details
Main Authors: Majoni, Sandawana William, Nelson, Jane, Germaine, Darren, Hoppo, Libby, Long, Stephanie, Divakaran, Shilpa, Turner, Brandon, Graham, Jessica, Cherian, Sajiv, Pawar, Basant, Rathnayake, Geetha, Heron, Bianca, Maple-Brown, Louise, Batey, Robert, Morris, Peter, Davies, Jane, Fernandes, David Kiran, Sundaram, Madhivanan, Abeyaratne, Asanga, Wong, Yun Hui Sheryl, Lawton, Paul D., Taylor, Sean, Barzi, Federica, Cass, Alan
Format: Article in Journal/Newspaper
Language:unknown
Published: figshare 2021
Subjects:
Online Access:https://dx.doi.org/10.6084/m9.figshare.c.5735684.v1
https://springernature.figshare.com/collections/INFERR-Iron_infusion_in_haemodialysis_study_INtravenous_iron_polymaltose_for_First_Nations_Australian_patients_with_high_FERRitin_levels_on_haemodialysis_a_protocol_for_a_prospective_open-label_blinded_endpoint_randomised_controlled_trial/5735684/1
id ftdatacite:10.6084/m9.figshare.c.5735684.v1
record_format openpolar
spelling ftdatacite:10.6084/m9.figshare.c.5735684.v1 2024-04-28T08:18:58+00:00 INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ... Majoni, Sandawana William Nelson, Jane Germaine, Darren Hoppo, Libby Long, Stephanie Divakaran, Shilpa Turner, Brandon Graham, Jessica Cherian, Sajiv Pawar, Basant Rathnayake, Geetha Heron, Bianca Maple-Brown, Louise Batey, Robert Morris, Peter Davies, Jane Fernandes, David Kiran Sundaram, Madhivanan Abeyaratne, Asanga Wong, Yun Hui Sheryl Lawton, Paul D. Taylor, Sean Barzi, Federica Cass, Alan 2021 https://dx.doi.org/10.6084/m9.figshare.c.5735684.v1 https://springernature.figshare.com/collections/INFERR-Iron_infusion_in_haemodialysis_study_INtravenous_iron_polymaltose_for_First_Nations_Australian_patients_with_high_FERRitin_levels_on_haemodialysis_a_protocol_for_a_prospective_open-label_blinded_endpoint_randomised_controlled_trial/5735684/1 unknown figshare https://dx.doi.org/10.6084/m9.figshare.c.5735684 Creative Commons Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/legalcode cc-by-4.0 Medicine Neuroscience Biotechnology Sociology FOS Sociology Hematology Infectious Diseases FOS Health sciences Collection article 2021 ftdatacite https://doi.org/10.6084/m9.figshare.c.5735684.v110.6084/m9.figshare.c.5735684 2024-04-02T12:02:50Z Abstract Background The effectiveness of erythropoiesis-stimulating agents, which are the main stay of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate body iron stores. The iron stores are determined by the levels of serum ferritin concentration and transferrin saturation. These two surrogate markers of iron stores are used to guide iron replacement therapy. Most Aboriginal and/or Torres Islander Australians of the Northern Territory (herein respectfully referred to as First Nations Australians) with end-stage kidney disease have ferritin levels higher than current guideline recommendations for iron therapy. There is no clear evidence to guide safe and effective treatment with iron in these patients. We aim to assess the impact of intravenous iron treatment on all-cause death and hospitalisation with a principal diagnosis of all-cause infection in First Nations patients on haemodialysis with anaemia, high ferritin levels and low transferrin saturation Methods In a ... Article in Journal/Newspaper First Nations DataCite Metadata Store (German National Library of Science and Technology)
institution Open Polar
collection DataCite Metadata Store (German National Library of Science and Technology)
op_collection_id ftdatacite
language unknown
topic Medicine
Neuroscience
Biotechnology
Sociology
FOS Sociology
Hematology
Infectious Diseases
FOS Health sciences
spellingShingle Medicine
Neuroscience
Biotechnology
Sociology
FOS Sociology
Hematology
Infectious Diseases
FOS Health sciences
Majoni, Sandawana William
Nelson, Jane
Germaine, Darren
Hoppo, Libby
Long, Stephanie
Divakaran, Shilpa
Turner, Brandon
Graham, Jessica
Cherian, Sajiv
Pawar, Basant
Rathnayake, Geetha
Heron, Bianca
Maple-Brown, Louise
Batey, Robert
Morris, Peter
Davies, Jane
Fernandes, David Kiran
Sundaram, Madhivanan
Abeyaratne, Asanga
Wong, Yun Hui Sheryl
Lawton, Paul D.
Taylor, Sean
Barzi, Federica
Cass, Alan
INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
topic_facet Medicine
Neuroscience
Biotechnology
Sociology
FOS Sociology
Hematology
Infectious Diseases
FOS Health sciences
description Abstract Background The effectiveness of erythropoiesis-stimulating agents, which are the main stay of managing anaemia of chronic kidney disease (CKD), is largely dependent on adequate body iron stores. The iron stores are determined by the levels of serum ferritin concentration and transferrin saturation. These two surrogate markers of iron stores are used to guide iron replacement therapy. Most Aboriginal and/or Torres Islander Australians of the Northern Territory (herein respectfully referred to as First Nations Australians) with end-stage kidney disease have ferritin levels higher than current guideline recommendations for iron therapy. There is no clear evidence to guide safe and effective treatment with iron in these patients. We aim to assess the impact of intravenous iron treatment on all-cause death and hospitalisation with a principal diagnosis of all-cause infection in First Nations patients on haemodialysis with anaemia, high ferritin levels and low transferrin saturation Methods In a ...
format Article in Journal/Newspaper
author Majoni, Sandawana William
Nelson, Jane
Germaine, Darren
Hoppo, Libby
Long, Stephanie
Divakaran, Shilpa
Turner, Brandon
Graham, Jessica
Cherian, Sajiv
Pawar, Basant
Rathnayake, Geetha
Heron, Bianca
Maple-Brown, Louise
Batey, Robert
Morris, Peter
Davies, Jane
Fernandes, David Kiran
Sundaram, Madhivanan
Abeyaratne, Asanga
Wong, Yun Hui Sheryl
Lawton, Paul D.
Taylor, Sean
Barzi, Federica
Cass, Alan
author_facet Majoni, Sandawana William
Nelson, Jane
Germaine, Darren
Hoppo, Libby
Long, Stephanie
Divakaran, Shilpa
Turner, Brandon
Graham, Jessica
Cherian, Sajiv
Pawar, Basant
Rathnayake, Geetha
Heron, Bianca
Maple-Brown, Louise
Batey, Robert
Morris, Peter
Davies, Jane
Fernandes, David Kiran
Sundaram, Madhivanan
Abeyaratne, Asanga
Wong, Yun Hui Sheryl
Lawton, Paul D.
Taylor, Sean
Barzi, Federica
Cass, Alan
author_sort Majoni, Sandawana William
title INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
title_short INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
title_full INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
title_fullStr INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
title_full_unstemmed INFERR-Iron infusion in haemodialysis study: INtravenous iron polymaltose for First Nations Australian patients with high FERRitin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
title_sort inferr-iron infusion in haemodialysis study: intravenous iron polymaltose for first nations australian patients with high ferritin levels on haemodialysis—a protocol for a prospective open-label blinded endpoint randomised controlled trial ...
publisher figshare
publishDate 2021
url https://dx.doi.org/10.6084/m9.figshare.c.5735684.v1
https://springernature.figshare.com/collections/INFERR-Iron_infusion_in_haemodialysis_study_INtravenous_iron_polymaltose_for_First_Nations_Australian_patients_with_high_FERRitin_levels_on_haemodialysis_a_protocol_for_a_prospective_open-label_blinded_endpoint_randomised_controlled_trial/5735684/1
genre First Nations
genre_facet First Nations
op_relation https://dx.doi.org/10.6084/m9.figshare.c.5735684
op_rights Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
cc-by-4.0
op_doi https://doi.org/10.6084/m9.figshare.c.5735684.v110.6084/m9.figshare.c.5735684
_version_ 1797582702169292800